Sponsors (10)
The bill prioritizes stronger, more transparent, and evidence‑based vaccine recommendations and injury‑table decisions and speeds consideration of new vaccines, while introducing tighter deadlines, potential rigidity and legal risk in decisionmaking, modest recurring taxpayer costs, and concerns about perceived industry influence.
People seeking and receiving vaccines will see vaccine guidance and changes tied to a clear, legally specified scientific standard (preponderance of best available, peer‑reviewed evidence), strengthening the scientific rigor of both ACIP recommendations and Vaccine Injury Table decisions.
Children and Medicaid‑eligible youth will have clearer statutory immunization schedules for VFC purchasing and coverage, improving vaccine access for eligible kids.
Newly licensed vaccines and new indications will be considered on a faster, regular timetable with a statutory (90‑day) recommendation deadline, speeding potential access to vaccines for patients.
Tight statutory deadlines (90 days) for ACIP recommendations could pressure deliberations and risk rushed or incomplete guidance on complex vaccine evidence, potentially affecting patient safety and public confidence.
Requiring the Director to adopt ACIP recommendations unless they fail the preponderance standard may reduce executive flexibility to weigh non‑scientific implementation factors (cost, logistics), limiting practical decisionmaking for health systems.
A higher, statutory evidentiary threshold increases the chance of legal disputes over what qualifies as the 'preponderance of the best available scientific evidence,' raising administrative burden and litigation costs for HHS and claimants.
Based on analysis of 3 sections of legislative text.
Codifies ACIP into statute, sets evidentiary standards and timelines for vaccine recommendations, and requires a preponderance of peer‑reviewed evidence to alter the Vaccine Injury Table.
Official title: Amend the Public Health Service Act to codify the Advisory Committee on Immunization Practices, and for other purposes.
Introduced December 3, 2025 by John Wright Hickenlooper · Last progress December 3, 2025
Codifies the existing Advisory Committee on Immunization Practices (ACIP) into statute, prescribes how ACIP must evaluate and recommend use of licensed vaccines and related agents, and raises the evidentiary standard for changes to the Vaccine Injury Table so removals or other modifications must be supported by a preponderance of the best available, peer‑reviewed scientific evidence. The bill requires the CDC Director to adopt ACIP recommendations unless the Director finds they are not supported by that standard, creates timelines and notification rules for consideration of new vaccines or indications, and requires prompt public reporting when recommendations are rejected.